The vermiform appendix and recurrent clostridium difficile infection: A curious connection

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 12, 2011, Pages 1017-1019

  Na, Xi ^a   Kelly, Ciáran ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; FIDAXOMICIN; METRONIDAZOLE; PROBIOTIC AGENT; RIFAXIMIN; VANCOMYCIN;

APPENDECTOMY; APPENDICITIS; APPENDIX; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; IMMUNE RESPONSE; RISK FACTOR; ULCERATIVE COLITIS;

APPENDIX; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; MALE;

EID: 82955203186     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.08.025     Document Type: Editorial

References (35)

1. Kelly C.P., LaMont J.T. Clostridium difficile: more difficult than ever. N Engl J Med 2008, 359:1932-1940.
2. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
3. Kelly C.P., Pothoulakis C., LaMont J.T. Clostridium difficile colitis. N Engl J Med 1994, 330:257-262.
4. Kyne L., Hamel M.B., Polavaram R., et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002, 34:346-353.
5. Vonberg R.P., Reichardt C., Behnke M., et al. Costs of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect 2008, 70:15-20.
6. Redelings M.D., Sorvillo F., Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007, 13:1417-1419.
7. McFarland L.V., Elmer G.W., Surawicz C.M. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 2002, 97:1769-1775.
8. Do A.N., Fridkin S.K., Yechouron A., et al. Risk factors for early recurrent Clostridium difficile-associated diarrhea. Clin Infect Dis 1998, 26:954-959.
9. Fekety R., McFarland L.V., Surawicz C.M., et al. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997, 24:324-333.
10. Gerding D.N., Muto C.A., Owens R.C. Treatment of Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl 1):S32-S42.
11. Kyne L., Kelly C.P. Recurrent Clostridium difficile diarrhoea. Gut 2001, 49:152-153.
12. Maroo S., Lamont J.T. Recurrent Clostridium difficile. Gastroenterology 2006, 130:1311-1316.
13. McFarland L.V., Surawicz C.M., Rubin M., et al. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999, 20:43-50.
14. Louie T.J., Miller M.A., Mullane K.M., et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011, 364:422-431.
15. Hu M.Y., Katchar K., Kyne L., et al. Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection. Gastroenterology 2009, 136:1206-1214.
16. Garey K.W., Sethi S., Yadav Y., et al. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008, 70:298-304.
17. Kyne L., Warny M., Qamar A., et al. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001, 357:189-193.
18. Im G.Y., Modayil R.J., Lin C.T., et al. The appendix may protect against Clostridium difficile recurrence. Clin Gastroenterol Hepatol 2011, 9:1072-1077.
19. Bollinger R.R., Barbas A.S., Bush E.L., et al. Biofilms in the normal human large bowel: fact rather than fiction. Gut 2007, 56:1481-1482.
20. Sonnenburg J.L., Angenent L.T., Gordon J.I. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?. Nat Immunol 2004, 5:569-573.
21. Allen A., Pearson J.P. The gastrointestinal adherent mucous gel barrier. Methods Mol Biol 2000, 125:57-64.
22. Atuma C., Strugala V., Allen A., et al. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 2001, 280:G922-G929.
23. Palestrant D., Holzknecht Z.E., Collins B.H., et al. Microbial biofilms in the gut: visualization by electron microscopy and by acridine orange staining. Ultrastruct Pathol 2004, 28:23-27.
24. Randal Bollinger R., Barbas A.S., Bush E.L., et al. Biofilms in the large bowel suggest an apparent function of the human vermiform appendix. J Theor Biol 2007, 249:826-831.
25. Kelly C.P., Kyne L. The host immune response to Clostridium difficile. J Med Microbiol 2011, 60:1070-1079.
26. Bollinger R.R., Everett M.L., Wahl S.D., et al. Secretory IgA and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol Immunol 2006, 43:378-387.
27. Bollinger R.R., Everett M.L., Palestrant D., et al. Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 2003, 109:580-587.
28. Orndorff P.E., Devapali A., Palestrant S., et al. Immunoglobulin-mediated agglutination of and biofilm formation by Escherichia coli K-12 require the type 1 pilus fiber. Infect Immun 2004, 72:1929-1938.
29. Friman V., Adlerberth I., Connell H., et al. Decreased expression of mannose-specific adhesins by Escherichia coli in the colonic microflora of immunoglobulin A-deficient individuals. Infect Immun 1996, 64:2794-2798.
30. Wold A.E., Adlerberth I. Breast feeding and the intestinal microflora of the infant: implications for protection against infectious diseases. Adv Exp Med Biol 2000, 478:77-93.
31. Andersson R.E., Olaison G., Tysk C., et al. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001, 344:808-814.
32. Järnerot G., Andersson M., Franzén L. Laparoscopic appendectomy in patients with refractory ulcerative colitis. Gastroenterology 2001, 120:1562-1563.
33. Jo Y., Matsumoto T., Yada S., et al. Histological and immunological features of appendix in patients with ulcerative colitis. Dig Dis Sci 2003, 48:99-108.
34. Okazaki K., Onodera H., Watanabe N., et al. A patient with improvement of ulcerative colitis after appendectomy. Gastroenterology 2000, 119:502-506.
35. Lowy I., Molrine D.C., Leav B.A., et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010, 362:197-205.